Photoaffinity Labeling of the Benzodiazepine Binding Site of α1β3γ2 γ-Aminobutyric AcidA Receptors with Flunitrazepam Identifies a Subset of Ligands that Interact Directly with His102 of the α Subunit and Predicts Orientation of These within the Benzodiazepine Pharmacophore

1998 ◽  
Vol 54 (1) ◽  
pp. 33-43 ◽  
Author(s):  
Ruth M. McKernan ◽  
Sophie Farrar ◽  
Ian Collins ◽  
Frances Emms ◽  
Ayodeji Asuni ◽  
...  
Keyword(s):  
Binding Site ◽  
Photoaffinity Labeling ◽  
Α Subunit ◽  
Benzodiazepine Binding

scholarly journals Influence of GABAA Receptor α Subunit Isoforms on the Benzodiazepine Binding Site

PLoS ONE ◽  
2012 ◽  
Vol 7 (7) ◽  
pp. e42101 ◽  
Author(s):  
Benjamin P. Lüscher ◽  
Roland Baur ◽  
Maurice Goeldner ◽  
Erwin Sigel
Keyword(s):  
Binding Site ◽  
Gabaa Receptor ◽  
Α Subunit ◽  
Benzodiazepine Binding ◽  
Subunit Isoforms

scholarly journals Identification of the Bovine γ-Aminobutyric Acid Type A Receptor α Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513

2002 ◽  
Vol 277 (51) ◽  
pp. 50036-50045 ◽  
Author(s):  
Gregory W. Sawyer ◽  
David C. Chiara ◽  
Richard W. Olsen ◽  
Jonathan B. Cohen
Keyword(s):  
Amino Acids ◽  
Sequence Analysis ◽  
Binding Site ◽  
Type A ◽  
Homology Model ◽  
Aminobutyric Acid ◽  
Modulate Function ◽  
Α Subunit ◽  
Acid Type ◽  
Benzodiazepine Binding

Ligands binding to the benzodiazepine-binding site in γ-aminobutyric acid type A (GABAA) receptors may allosterically modulate function. Depending upon the ligand, the coupling can either be positive (flunitrazepam), negative (Ro15-4513), or neutral (flumazenil). Specific amino acid determinants of benzodiazepine binding affinity and/or allosteric coupling have been identified within GABAAreceptor α and γ subunits that localize the binding site at the subunit interface. Previous photolabeling studies with [3H]flunitrazepam identified a primary site of incorporation at α1His-102, whereas studies with [3H]Ro15-4513 suggested incorporation into the α1subunit at unidentified amino acids C-terminal to α1His-102. To determine the site(s) of photoincorporation by Ro15-4513, we affinity-purified (∼200-fold) GABAAreceptor from detergent extracts of bovine cortex, photolabeled it with [3H]Ro15-4513, and identified3H-labeled amino acids by N-terminal sequence analysis of subunit fragments generated by sequential digestions with a panel of proteases. The patterns of3H release seen after each digestion of the labeled fragments determined the number of amino acids between the cleavage site and labeled residue, and the use of sequential proteolytic fragmentation identified patterns of cleavage sites unique to the different α subunits. Based upon this radiochemical sequence analysis, [3H]Ro15-4513 was found to selectively label the homologous tyrosines α1Tyr-210, α2Tyr-209, and α3Tyr-234, in GABAAreceptors containing those subunits. These results are discussed in terms of a homology model of the benzodiazepine-binding site based on the molluscan acetylcholine-binding protein structure.

scholarly journals Competitive Antagonism of Etomidate Action by Diazepam

2020 ◽  
Vol 133 (3) ◽  
pp. 583-594 ◽  
Author(s):  
Megan McGrath ◽  
Helen Hoyt ◽  
Andrea Pence ◽  
Selwyn S. Jayakar ◽  
Xiaojuan Zhou ◽  
...  
Keyword(s):  
Binding Site ◽  
Gabaa Receptor ◽  
Gabaa Receptors ◽  
Response Curve ◽  
Photoaffinity Labeling ◽  
Peak Current ◽  
Benzodiazepine Binding ◽  
Concentration Response Curve

Background Recent cryo-electron microscopic imaging studies have shown that in addition to binding to the classical extracellular benzodiazepine binding site of the α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor, diazepam also binds to etomidate binding sites located in the transmembrane receptor domain. Because such binding is characterized by low modulatory efficacy, the authors hypothesized that diazepam would act in vitro and in vivo as a competitive etomidate antagonist. Methods The concentration-dependent actions of diazepam on 20 µM etomidate-activated and 6 µM GABA-activated currents were defined (in the absence and presence of flumazenil) in oocyte-expressed α1β3γ2L GABAA receptors using voltage clamp electrophysiology. The ability of diazepam to inhibit receptor labeling of purified α1β3γ2L GABAA receptors by 3[H]azietomidate was assessed in photoaffinity labeling protection studies. The impact of diazepam (in the absence and presence of flumazenil) on the anesthetic potencies of etomidate and ketamine was compared in a zebrafish model. Results At nanomolar concentrations, diazepam comparably potentiated etomidate-activated and GABA-activated GABAA receptor peak current amplitudes in a flumazenil-reversible manner. The half-maximal potentiating concentrations were 39 nM (95% CI, 27 to 55 nM) and 26 nM (95% CI, 16 to 41 nM), respectively. However, at micromolar concentrations, diazepam reduced etomidate-activated, but not GABA-activated, GABAA receptor peak current amplitudes in a concentration-dependent manner with a half-maximal inhibitory concentration of 9.6 µM (95% CI, 7.6 to 12 µM). Diazepam (12.5 to 50 µM) also right-shifted the etomidate-concentration response curve for direct activation without reducing the maximal response and inhibited receptor photoaffinity labeling by 3[H]azietomidate. When administered with flumazenil, 50 µM diazepam shifted the etomidate (but not the ketamine) concentration–response curve for anesthesia rightward, increasing the etomidate EC50 by 18-fold. Conclusions At micromolar concentrations and in the presence of flumazenil to inhibit allosteric modulation via the classical benzodiazepine binding site of the GABAA receptor, diazepam acts as an in vitro and in vivo competitive etomidate antagonist. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New

scholarly journals Silencing of the Gene for the α-Subunit of Human Chorionic Gonadotropin by the Embryonic Transcription Factor Oct-3/4

1997 ◽  
Vol 11 (11) ◽  
pp. 1651-1658 ◽  
Author(s):  
Limin Liu ◽  
Douglas Leaman ◽  
Michel Villalta ◽  
R. Michael Roberts
Keyword(s):  
Transcription Factor ◽  
Binding Site ◽  
Gene Promoter ◽  
Site Directed Mutagenesis ◽  
Mobility Shift ◽  
Α Subunit ◽  
Choriocarcinoma Cells ◽  
Human Choriocarcinoma Cells ◽  
Electrophoretic Mobility Shift Assays ◽  
Jar Cells

Abstract CG is required for maintenance of the corpus luteum during pregnancy in higher primates. As CG is a heterodimeric molecule, some form of coordinated control must be maintained over the transcription of its two subunit genes. We recently found that expression of human CG β-subunit (hCGβ) in JAr human choriocarcinoma cells was almost completely silenced by the embryonic transcription factor Oct-3/4, which bound to a unique ACAATAATCA octameric sequence in the hCGβ gene promoter. Here we report that Oct-3/4 is also a potent inhibitor of hCG α-subunit (hCGα) expression in JAr cells. Oct-3/4 reduced human GH reporter expression from the −170 hCGα promoter in either the presence or absence of cAMP by about 70% in transient cotransfection assays, but had no effect on expression from either the −148 hCGα or the −99 hCGα promoter. Unexpectedly, no Oct-3/4-binding site was identified within the −170 to −148 region of the hCGα promoter, although one was found around position −115 by both methylation interference footprinting and electrophoretic mobility shift assays. Site-directed mutagenesis of this binding site destroyed the affinity of the promoter for Oct-3/4, but did not affect repression of the promoter. Therefore, inhibition of hCGα gene transcription by Oct-3/4 appears not to involve direct binding of this factor to the site responsible for silencing. When stably transfected into JAr cells, Oct-3/4 reduced the amounts of both endogenous hCGα mRNA and protein by 70–80%. Oct-3/4 is therefore capable of silencing both hCGα and hCGβ gene expression. We suggest that as the trophoblast begins to form, reduction of Oct-3/4 expression permits the coordinated onset of transcription from the hCGα and hCGβ genes.

scholarly journals On the Interaction between Amiloride and Its Putative α-Subunit Epithelial Na+Channel Binding Site

2005 ◽  
Vol 280 (28) ◽  
pp. 26206-26215 ◽  
Author(s):  
Ossama B. Kashlan ◽  
Shaohu Sheng ◽  
Thomas R. Kleyman
Keyword(s):  
Binding Site ◽  
Na Channel ◽  
Α Subunit ◽  
Epithelial Na Channel

scholarly journals Hyperpolarization-activated inward leakage currents caused by deletion or mutation of carboxy-terminal tyrosines of the Na+/K+-ATPase α subunit

2010 ◽  
Vol 135 (2) ◽  
pp. 115-134 ◽  
Author(s):  
Susan Meier ◽  
Neslihan N. Tavraz ◽  
Katharina L. Dürr ◽  
Thomas Friedrich
Keyword(s):  
Binding Site ◽  
Critical Role ◽  
Aromatic Amino Acids ◽  
Cation Binding ◽  
Carboxy Terminus ◽  
Leakage Currents ◽  
Α Subunit ◽  
Inward Currents ◽  
The Common ◽  
Carboxy Terminal

The Na+/K+-ATPase mediates electrogenic transport by exporting three Na+ ions in exchange for two K+ ions across the cell membrane per adenosine triphosphate molecule. The location of two Rb+ ions in the crystal structures of the Na+/K+-ATPase has defined two “common” cation binding sites, I and II, which accommodate Na+ or K+ ions during transport. The configuration of site III is still unknown, but the crystal structure has suggested a critical role of the carboxy-terminal KETYY motif for the formation of this “unique” Na+ binding site. Our two-electrode voltage clamp experiments on Xenopus oocytes show that deletion of two tyrosines at the carboxy terminus of the human Na+/K+-ATPase α2 subunit decreases the affinity for extracellular and intracellular Na+, in agreement with previous biochemical studies. Apparently, the ΔYY deletion changes Na+ affinity at site III but leaves the common sites unaffected, whereas the more extensive ΔKETYY deletion affects the unique site and the common sites as well. In the absence of extracellular K+, the ΔYY construct mediated ouabain-sensitive, hyperpolarization-activated inward currents, which were Na+ dependent and increased with acidification. Furthermore, the voltage dependence of rate constants from transient currents under Na+/Na+ exchange conditions was reversed, and the amounts of charge transported upon voltage pulses from a certain holding potential to hyperpolarizing potentials and back were unequal. These findings are incompatible with a reversible and exclusively extracellular Na+ release/binding mechanism. In analogy to the mechanism proposed for the H+ leak currents of the wild-type Na+/K+-ATPase, we suggest that the ΔYY deletion lowers the energy barrier for the intracellular Na+ occlusion reaction, thus destabilizing the Na+-occluded state and enabling inward leak currents. The leakage currents are prevented by aromatic amino acids at the carboxy terminus. Thus, the carboxy terminus of the Na+/K+-ATPase α subunit represents a structural and functional relay between Na+ binding site III and the intracellular cation occlusion gate.

Sign in / Sign up

Export Citation Format

Share Document